Updated Clinical Practice Guidelines for Noninvasive Lower Back Pain Treatments

Lauren Santye, Assistant Editor
Published Online: Tuesday, February 14th, 2017
The American College of Physicians (ACP) released updated guidelines on noninvasive treatment of lower back pain that alter prior guidelines calling for medication as first-line therapy.

The committee used the ACP grading system to base the recommendations on a systematic review of randomized, controlled trials, and systematic reviews published through April 2015 on noninvasive pharmacologic and nonpharmacologic treatments for low back pain.

Since most patients with acute or subacute low back pain improve over time regardless of treatments, the ACP recommends that clinicians and patients select nonpharmacological treatment with superficial heat, massage, acupuncture, or spinal manipulation.

“If pharmacologic treatment is desired, clinicians and patients should select nonsteroidal anti-inflammatory drugs or skeletal muscle relaxants (moderate-quality evidence),” according to the guidelines.

For patients with chronic low back pain, the guidelines recommend that patients and clinicians should initially select nonpharmacological treatment with exercise, multidisciplinary rehabilitation, acupuncture, mindfulness-based stress reduction (moderate-quality evidence), tai chi, yoga, motor control exercise, low-level laser therapy, progressive relaxation, electromyography biofeedback, cognitive behavioral therapy, operant therapy, or spinal manipulation (low-quality evidence).

Third, patients with chronic low back pain who have had an inadequate response to nonpharmacologic therapy should consider pharmacologic treatment with nonsteroidal anti-inflammatory drugs as first-line therapy, or tramadol or duloxetine as second-line therapy. However, the ACP said prescribing opioid painkillers should be avoided.

“Clinicians should only consider opioids as an option in patients who have failed the aforementioned treatments and only if the potential benefits outweigh the risks for individual patients and after a discussion of known risks and realistic benefits with patients. (Grade: weak recommendation, moderate-quality evidence).”

Dr. James Weinstein, back specialist and chief executive of Dartmouth-Hitchcock Health System, told the New York Times, “What we need to do is to stop medicalizing symptoms; pills are not going to make people better. [As for other treatments] yoga and tai chi, all those things are wonderful, but why not just go back to normal activities.”

Current Issue

The Educated Patient

Mary McCormack, MSN, APNC, MPH
The World Gastroenterology Organization describes the prevalence of celiac disease as a “statistical iceberg” in today’s health climate.
Melissa DeCapua, DNP, PMHNP-B-C
Diabetic retinopathy causes more losses of vision worldwide than any other eye disease, affecting 33% of the 285 million individuals suffering from diabetes.
Janet Gilbreath, DNP, MBA, MSN, FNP-BC
Head lice are 6-legged insects about the size of a sesame seed that cling to the scalp and neck and survive by feeding on human blood.
Ginger K. Urban, DHSc, PA-C
Heatstroke occurs when your body can no longer cool itself and your body temperature becomes dangerously high.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Contact Us
Terms & Conditions
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.